Novo Nordisk (NOVOB DC) CEO says the Chinese market for obesity drug is not growing as much as Co. had anticipated

05 Nov 2025 - 12:46- - Source: Newswires

NOVOB.DCNovo Nordisk A/SEuropean EquitiesChinaEU SessionUS SessionEU SessionUS SessionAsia

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: